Australia and New Zealand
Great People. Great Products. Greater Opportunity.
Allergan Aesthetics is an AbbVie (NYSE: ABBV) company that develops, manufactures and markets a portfolio of leading aesthetics brands and products for consumers around the world.
The Allergan Aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more.
With its own research and development team focused on driving innovation in aesthetics, Allergan Aesthetics is committed to providing the most comprehensive science-based product offerings available.
Senior Vice President AbbVie, and President, Global Allergan Aesthetics
Carrie Strom is Senior Vice President AbbVie, and President Global Allergan Aesthetics and has served in this role since May 2020.
AU-ABBV-210499 V1 DoP: November 2021